Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Franco Folli

Showing results (41-50 of 166) with videos related to

Pageof 17
Sort By:
Movement Disorders : Official Journal of the Movement Disorder Society|June 19, 2007
PET evidence of central GABAergic changes in stiff-person syndromeDaniela Perani, Valentina Garibotto, Andrea Panzacchi, et al.
Current Vascular Pharmacology|December 15, 2010
Medical therapy of aortic aneurysms: a pathophysiology-based approachGiovanna Muscogiuri, Gian Pio Sorice, Devjit Tripathy, et al.
Diabetes Care|June 3, 2009
Circulating fibroblast growth factor-21 is elevated in impaired glucose tolerance and type 2 diabetes and correlates with muscle and hepatic insulin resistanceAlberto O Chavez, Marjorie Molina-Carrion, Muhammad A Abdul-Ghani, et al.
Cardiovascular Diabetology|July 22, 2009
Biliary pancreatic diversion and laparoscopic adjustable gastric banding in morbid obesity: their long-term effects on metabolic syndrome and on cardiovascular parametersAntonio E Pontiroli, Marco Laneri, Annamaria Veronelli, et al.
Cardiovascular Diabetology|March 25, 2023
Time-dependent effect of GLP-1 receptor agonists on cardiovascular benefits: a real-world studySara Piccini, Giuseppe Favacchio, Cristina Panico, et al.
International Journal of Cardiology|August 11, 2004
Apoptotic/mytogenic pathways during human heart developmentPaolo Fiorina, Domenico Corradi, Silvana Pinelli, et al.
Cardiovascular Diabetology|December 31, 2018
A 23-year study of mortality and development of co-morbidities in patients with obesity undergoing bariatric surgery (laparoscopic gastric banding) in comparison with medical treatment of obesityAntonio E Pontiroli, Ahmed S Zakaria, Marco Fanchini, et al.
Pharmaceuticals (Basel, Switzerland)|January 8, 2025
N-methyl-D-aspartate Receptors and Depression: Linking Psychopharmacology, Pathology and Physiology in a Unifying Hypothesis for the Epigenetic Code of Neural PlasticityStefano Comai, Sara De Martin, Andrea Mattarei, et al.
Diabetes Care|June 19, 2015
Sclerostin and Insulin Resistance in Prediabetes: Evidence of a Cross Talk Between Bone and Glucose MetabolismGiuseppe Daniele, Deidre Winnier, Andrea Mari, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|June 8, 2021
Physical activity as a proxy to ameliorate inflammation in patients with type 2 diabetes and periodontal disease at high cardiovascular riskRoberto Codella, Lucio Della Guardia, Ileana Terruzzi, et al.
Pageof 17

Showing results (41-50 of 166) with videos related to

Sort By:
Pageof 17
Movement Disorders : Official Journal of the Movement Disorder Society|June 19, 2007
PET evidence of central GABAergic changes in stiff-person syndromeDaniela Perani, Valentina Garibotto, Andrea Panzacchi, et al.
Current Vascular Pharmacology|December 15, 2010
Medical therapy of aortic aneurysms: a pathophysiology-based approachGiovanna Muscogiuri, Gian Pio Sorice, Devjit Tripathy, et al.
Diabetes Care|June 3, 2009
Circulating fibroblast growth factor-21 is elevated in impaired glucose tolerance and type 2 diabetes and correlates with muscle and hepatic insulin resistanceAlberto O Chavez, Marjorie Molina-Carrion, Muhammad A Abdul-Ghani, et al.
Cardiovascular Diabetology|July 22, 2009
Biliary pancreatic diversion and laparoscopic adjustable gastric banding in morbid obesity: their long-term effects on metabolic syndrome and on cardiovascular parametersAntonio E Pontiroli, Marco Laneri, Annamaria Veronelli, et al.
Cardiovascular Diabetology|March 25, 2023
Time-dependent effect of GLP-1 receptor agonists on cardiovascular benefits: a real-world studySara Piccini, Giuseppe Favacchio, Cristina Panico, et al.
International Journal of Cardiology|August 11, 2004
Apoptotic/mytogenic pathways during human heart developmentPaolo Fiorina, Domenico Corradi, Silvana Pinelli, et al.
Cardiovascular Diabetology|December 31, 2018
A 23-year study of mortality and development of co-morbidities in patients with obesity undergoing bariatric surgery (laparoscopic gastric banding) in comparison with medical treatment of obesityAntonio E Pontiroli, Ahmed S Zakaria, Marco Fanchini, et al.
Pharmaceuticals (Basel, Switzerland)|January 8, 2025
N-methyl-D-aspartate Receptors and Depression: Linking Psychopharmacology, Pathology and Physiology in a Unifying Hypothesis for the Epigenetic Code of Neural PlasticityStefano Comai, Sara De Martin, Andrea Mattarei, et al.
Diabetes Care|June 19, 2015
Sclerostin and Insulin Resistance in Prediabetes: Evidence of a Cross Talk Between Bone and Glucose MetabolismGiuseppe Daniele, Deidre Winnier, Andrea Mari, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|June 8, 2021
Physical activity as a proxy to ameliorate inflammation in patients with type 2 diabetes and periodontal disease at high cardiovascular riskRoberto Codella, Lucio Della Guardia, Ileana Terruzzi, et al.
Pageof 17